Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
SMStacie M JonesEHEdwin H KimKCKari C NadeauANAnna Nowak-WegrzynRARobert A Wood
Arkansas Children's Hospital · University of Arkansas for Medical Sciences · +10 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
306
total citations
- FWCI
- 39.15
- Percentile
- 100%
- References
- 29
Citations per year
Authors
26- SMStacie M JonesCorresponding
Arkansas Children's Hospital, University of Arkansas for Medical Sciences
- EHEdwin H Kim
University of North Carolina at Chapel Hill
- KCKari C Nadeau
Stanford University
- ANAnna Nowak-Wegrzyn
NYU Langone Health, Icahn School of Medicine at Mount Sinai
- RARobert A Wood
Johns Hopkins Medicine, Johns Hopkins University
Topics & keywords
Topics
Keywords
- Peanut allergy
- Discontinuation
- Placebo
- Oral immunotherapy
- Immunotherapy
- Clinical trial
- Allergy
- Food allergy
No related works found for this paper.